Vstm stocktwits.

Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib (VS-6063), an orally available candidate ...Verastem, Inc. Common Stock (VSTM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Verastem's CEO is Dan Paterson, appointed in Jun 2019, has a tenure of 4.33 years. total yearly compensation is $697.98K, comprised of 67.3% salary and 32.7% bonuses, including company stock and options. VSTM US92337C2035 Delayed Nasdaq. Other stock markets. 04:00:00 2023-10-05 pm EDT 5-day change 1st Jan Change 7.750 USD +4.73%-6.85% +60.46%: Sep. 27: B. Riley Starts Verastem at Buy With $21 PT, Notes Likely Accelerated Approval of Avutometinib + defactinib for Low-Grade Serous Ovarian Cancer ...Verastem, Inc. (VSTM) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.01 +0.26 (+3.35%) At close: 04:00PM EDT

Tomorrow's movement Prediction of Verastem, Inc. VSTM appears to be in downtrend. But this trend seems to be weakening. Price is below an important level of 9.97 on charts, and if price remains below this level, then stock might show a fall in short term. Tomorrow's movement Prediction of Verastem, Inc. VSTM made a major fall in previous days.

Oct 5, 2023 · Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 - 2011; Net Income

Verastem Inc. historical stock charts and prices, analyst ratings, financials, and today's real-time VSTM stock price.NasdaqGM:VSTM Earnings and Revenue Growth September 26th 2022. It looks like hedge funds own 25% of Verastem shares. That's interesting, because hedge funds can be quite active and activist. Many ...Verastem Oncology has received little in the way of analyst coverage over the past year. On May 24th, BTIG upgraded VSTM to a Buy from a Neutral rating and place a $8 price target on the shares. A ...VSTM's price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents. The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year.

VSTM Stock Predictions - will VSTM go up or down? - free VSTM analysis to find out whether to buy or sell VSTM. Secret Penny Stocks Guide +128.38%: ... Check out VSTM StockTwits on Stocktwits or Twitter to see what others have to say about the stock. Learn how to trade penny stocks. Complete Penny Stocks Guide;

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on Verastem (VSTM - Research Report) today and set a price target of $2.00.The company's shares closed yesterday at $0.43 ...

Sep 29, 2023 · Find the latest Verastem, Inc. (VSTM) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.Their AKBA share price forecasts range from $3.75 to $3.75. On average, they expect the company's share price to reach $3.75 in the next year. This suggests a possible upside of 253.8% from the stock's current price. View analysts price targets for AKBA or view top-rated stocks among Wall Street analysts.Oct 4, 2023 · A list of analyst ratings for Verastem (VSTM) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.

Verastem (NASDAQ:VSTM) shareholders have endured a 62% loss from investing in the stock five years ago. May 9, 2022.By Investing.com. • May 09, 2023. Investing.com - Verastem (NASDAQ: VSTM) reported first quarter EPS of $-0.090, worse than the analyst estimate of $-0.080. Revenue for the quarter came in at $0 ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe latest messages and market ideas from SEUNGJIN JEON (@vstm) on Stocktwits. The largest community for investors and traders Verastem has a market cap or net worth of $191.91 million as of October 10, 2023. Its market cap has increased by 20.24% in one year. Market Cap. 191.91M. Enterprise Value. 61.43M. 1-Year Change. 20.24%. Ranking.

VSTM Technical Analysis. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Verastem Inc stock. A detailed technical analysis through moving averages buy/sell signals ...VSTM, Jan. 11, 2018 / $3.02, Sept. 4, 2018 / $10.07, 233%. PreviousNext. Search ... StockTwits · StockTwits. © 2023 The Growth Portfolio Blog | Powered by ...

VSTM's price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents. The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year.Track Southwestern Energy Company (SWN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack ROBLOX CORPORATION (RBLX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVMW | Complete VMware Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...Verastem (VSTM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.VSTM (ZB_9894335.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock VSTM | Nasdaq: | NasdaqTrack Invesco QQQ Trust Series 1 (QQQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFundamentals. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered ...

Bristol-Myers Squibb Co. (NYSE:BMY) J.P. Morgan 41st Annual Healthcare Conference Call January 9, 2023 10:30 AM ETCompany Participants. Chris Boerner - Chief Commercial Officer. Conference Call ...

Q4 2023 EPS Estimate Trends. Current. -$0.67. 1 Month Ago. -$0.66. 3 Months Ago. -$0.82. Verastem Inc. analyst estimates, including VSTM earnings per share estimates and analyst recommendations.

Track Stem Inc (STEM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsOverview Key Ratios Trading Information Last Close 7.90 Sector Healthcare Industry Biotechnology Investment Style Small Value Day Range 7.69 – 7.94 Year Range 3.47 – 15.18 Market Cap 199.4806 Mil...Find the latest news for Verastem Stock on our page and stay on top of the game.An annual meager VSTM $100 million revenue for 2019 gets the price much closer to the analyst target as demonstrated earlier. This might be one reason. 40% of peer companies after 2010 companies ...Sync with Stocktwits. Latest VERASTEM (VSTM) stock news, Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developin...VSTM Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here or remove ads. Latest VSTM News Get all financial information for Verastem Inc (VSTM) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more Strong sell candidates identified by "Bad Apples" algorithm on Monday, July 10, 2017. Score (1 to 10) represents a signal strength for a position detected by "Bad Apples" algorithm. The higher the score, the larger the expected down move, the sooner down move shall occur, and the more liquid the position is. Last price is the latest ...Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.Review the latest analysis on Verastem Inc (VSTM:XNAS) stock to find out if this stock is the best investment for you based on Morningstar's analysis.

7.35. +0.30. +4.26%. Get Verastem Inc (VSTM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Verastem Oncology (NASDAQ: VSTM) is a biopharmaceutical company focused on exploring the unexplored to give patients diagnosed with cancer better options. Learn how VS-6766 and novel combinations may offer better control of the RAS and parallel pathways signaling to potentially expand the number of treatments for cancer patients.Complete Verastem Inc. stock information by Barron's. View real-time VSTM stock price and news, along with industry-best analysis.VSTM Stock valuations - Verastem Inc : the intrinsic value of the stock based on Peter Lynch Fair Value, DCF Earnings and more. 🚀 Enjoy a 7-Day Free Trial Thru Jan 29, 2023! Sign UpInstagram:https://instagram. entergy payment centert.j. maxx the runway locationsmap of yellowstone lodginggarden hose dollar general Aug 31, 2023 · Total Valuation. Verastem has a market cap or net worth of $249.98 million. The enterprise value is $105.61 million. Market Cap. 249.98M. Enterprise Value. 105.61M. league secretary arizonaanima touched weapon fragments Johnson John. Stock Option (right to buy) 85.773. Last 100 transactions. Buy: 8 207 851 | Sell: 709 484 (Shares) Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 85.773. In total, the insiders bought 8 207 851 and sold 709 484 VSTM shares in the last 100 trades. ksaz tv schedule This means patients quickly run out of therapeutic options. At Verastem Oncology, we're committed to ensuring options exist. For more information about the work we're doing at Verastem Oncology, please access our Resources section or contact Lisa Buffington by phone at (781) 292-4502 or via email at [email protected] historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.